Rosetta Genomics , a developer and provider of microRNA-based molecular diagnostics, entered into a collaborative research and license agreement with Yeda Research and Development, the commercial arm of the Weizmann Institute of Science . The ... Genetic Engineering News, 3 weeks ago
Rosetta Genomics Announces Next-Generation Sequencing Research Collaboration With Weizmann Institute of Science's Nancy and Stephen Grand Israel National Center for Personalized Medicine - Individual.com, 3 weeks ago
Rosetta Genomics Ltd. Announces Next-Generation Sequencing Research Collaboration With Weizmann Institute of Science's - BioSpace, 3 weeks ago
Weizmann Institute team identifies molecule that creates the depression-relieving chemical Serotonin in the brain. Israeli scientists have identified a brain chemical, which was previously unknown, that could prove to be a breakthrough in the ...Haaretz, 2 months ago
. announced today that it has received a license to use the Cntnap2 knockout mouse from Yeda R&D Co. Ltd., the technology transfer company of the Weizmann Institute of Science. The CNTNAP2 gene encodes for Contactin Associated Protein 2 (Caspr2), a ...Wall Street Select, 2 months ago
Researchers Submit Patent Application, "Social Network Based Education Infrastructure and Methods of Implementing and Using Social Network Based...
Researchers Submit Patent Application, "Social Network Based Education Infrastructure and Methods of Implementing and Using Social Network Based Education Infrastructures", for Approval By a News Reporter-Staff News Editor at Politics & Government ...HispanicBusiness.com, 3 weeks ago
Researchers Identify Unique Fingerprints of microRNA Molecule That Acts on Serotonin-Producing Nerve Cells
According the World Health Organization, such mood disorders as depression affect some 10% of the world's population and are associated with a heavy burden of disease. That is why numerous scientists around the world have invested a great deal of ...Azonano, 2 months ago Scientists "fingerprint" a culprit in depression, anxiety and other mood disorders Medical News Today, 1 month ago Weizmann Institute scientists 'fingerprint' a culprit in depression and anxiety disorders News-Medical.Net, 2 months ago Tiny molecule could help diagnose and treat mental disorders EurekAlert!, 2 months ago
CELL SOURCE, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations.
The information set forth below should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q, as well as with the financial statements and ...HispanicBusiness.com, 3 days ago BIOTIME INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations TMC Net, 1 week ago MOMENTA PHARMACEUTICALS INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations. TMC Net, 2 weeks ago
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.12 and the Introduction of GeneCards PlusTM
New release features powerful tools for registered members ALAMEDA, Calif.--( BUSINESS WIRE )--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the release of GeneCards ® Version 3.12. The new release is ...Business Wire, 1 month ago BioTime : LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.12 and the Introduction of GeneCards Plus 4 Traders, 1 month ago
CELL SOURCE, INC. FILES (8-K) Disclosing Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Results of Operations and Financial Condition, Changes in Registrant's Certifying Accountant, Unregistered Sale of Equ
Item 1.01 Entry into a Material Definitive Agreement. On June 30, 2014 (the "Closing Date"), Cell Source, Inc. f/k/a Ticket to See, Inc. ("TTSE" or the "Company") entered into and closed a share exchange agreement (the "Share Exchange Agreement") ...HispanicBusiness.com, 1 month ago
By screening for a tiny molecule in the brain, doctors may someday diagnose depression with a simple blood test. Scientists have recently uncovered the workings of a molecule called miR135 that seems to help regulate levels of serotonin, the ...Medical Daily, 2 months ago
on your WebpageAdd Widget >Get your members hooked!